These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38546768)

  • 1. Determinants of cancer screenings participation in Queensland: a scoping review.
    Lui PSC; Singh K; Nguyen T; Kurth B; Phan T; Nelson A; Danisevska R; De Ambrosis T
    J Prim Health Care; 2024 Mar; 16(1):70-77. PubMed ID: 38546768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with cervical cancer screening participation among migrant women in Europe: a scoping review.
    Marques P; Nunes M; Antunes MDL; Heleno B; Dias S
    Int J Equity Health; 2020 Sep; 19(1):160. PubMed ID: 32917224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of (non-)attendance at the Dutch cancer screening programmes: A systematic review.
    Bongaerts TH; Büchner FL; Middelkoop BJ; Guicherit OR; Numans ME
    J Med Screen; 2020 Sep; 27(3):121-129. PubMed ID: 31801039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer screening education: can it change knowledge and attitudes among culturally and linguistically diverse communities in Queensland, Australia?
    Cullerton K; Gallegos D; Ashley E; Do H; Voloschenko A; Fleming M; Ramsey R; Gould T
    Health Promot J Austr; 2016 Jun; 27(2):140-147. PubMed ID: 27376437
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: a scoping review of the literature.
    Greenley R; Bell S; Rigby S; Legood R; Kirkby V; McKee M;
    Front Public Health; 2023; 11():1144674. PubMed ID: 37304105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?
    Walpole E; Dunn N; Youl P; Harden H; Furnival C; Moore J; Taylor K; Evans E; Philpot S
    Int J Cancer; 2020 Aug; 147(3):856-865. PubMed ID: 31808149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Review and Meta-study Synthesis of Qualitative Studies Evaluating Facilitators and Barriers to Participation in Colorectal Cancer Screening.
    Honein-AbouHaidar GN; Kastner M; Vuong V; Perrier L; Daly C; Rabeneck L; Straus S; Baxter NN
    Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):907-17. PubMed ID: 27197277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of routine cervical screening participation in underserved women: a qualitative systematic review.
    Wearn A; Shepherd L
    Psychol Health; 2024; 39(2):145-170. PubMed ID: 35296200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review.
    Dressler J; Johnsen AT; Madsen LJ; Rasmussen M; Jorgensen LN
    Public Health; 2021 Jan; 190():67-74. PubMed ID: 33360029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions and implications for cervical screening and self-collection: A qualitative exploration of never and under-screened Queensland women.
    Haarsager J; Legerton P; DeBats C; Austin G; Vardon P
    Health Promot J Austr; 2023 Oct; 34(4):943-952. PubMed ID: 36828787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Cancer Screening Performance Indicators: A Systematic Review.
    Mema SC; Yang H; Vaska M; Elnitsky S; Jiang Z
    PLoS One; 2016; 11(8):e0161187. PubMed ID: 27518708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined patterns of participation in cervical, breast, and colorectal cancer screenings and factors for non-participation in each screening among women in Japan.
    Ishii K; Tabuchi T; Iso H
    Prev Med; 2021 Sep; 150():106627. PubMed ID: 34019930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast-cancer mortality in screened versus unscreened women: Long-term results from a population-based study in Queensland, Australia.
    Dunn N; Youl P; Moore J; Harden H; Walpole E; Evans E; Taylor K; Philpot S; Furnival C
    J Med Screen; 2021 Jun; 28(2):193-199. PubMed ID: 32842857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing organized colorectal cancer screening programs in Europe-protocol for a systematic review of determinants and strategies.
    Albers B; Auer R; Caci L; Nyantakyi E; Plys E; Podmore C; Riegel F; Selby K; Walder J; Clack L
    Syst Rev; 2023 Feb; 12(1):26. PubMed ID: 36849979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial and temporal variations in cervical cancer screening participation among indigenous and non-indigenous women, Queensland, Australia, 2008-2017.
    Dasgupta P; Aitken JF; Condon J; Garvey G; Whop LJ; DeBats C; Baade PD
    Cancer Epidemiol; 2020 Dec; 69():101849. PubMed ID: 33157511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
    PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and facilitators to cervical cancer screening among under-screened women in Cuenca, Ecuador: the perspectives of women and health professionals.
    Vega Crespo B; Neira VA; Ortíz Segarra J; Andrade A; Guerra G; Ortiz S; Flores A; Mora L; Verhoeven V; Gama A; Dias S; Verberckmoes B; Vermandere H; Michelsen K; Degomme O
    BMC Public Health; 2022 Nov; 22(1):2144. PubMed ID: 36414955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.